Information about Bard IVC Filter Lawsuits from Lawyers Handling IVC Filter Lawsuits

No-Cost, No-Obligation Bard IVC Filter Lawsuit Review

IVC Filter Lawsuits

A Report Published In 2006 Documented IVC Filter Catastrophies

Bard IVC Filter Lawsuits

An IVC filter may only trap blood clots temporarily and become the source if not removed

Tuesday, October 5, 2021 - The National Institute of Health has published extensively on the efficacy of the IVC filter medical device in the wake of hundreds of patient complaints to government regulators. Authors of the IVC filter study identify the three times a patient is most at risk as during the implanting of the filter when internal bleeding and infections could occur, after the device has been implanted as it can perforate the artery and migrate into the lungs or heart, and also during the filter's removal process when the device could become encased in scar tissue making it difficult if not impossible to remove without causing critical damage to the artery.

Physicians that implant the medical device, researchers, and scientists that study complaints have come to the general conclusion that the device could cause life-threatening complications if left in the body for more than a month or two. The paper, written in 2006, describes inferior vena cava (IVC) filter complications. It is hard to believe that CR Bard, the designers, manufacturers, and marketers of their IVC filter devices, were unaware of the device's risks. Bard IVC filters lawyers are interviewing prospective plaintiffs that have suffered from the faulty medical device. Patients in the hospital for surgeries unrelated to their heart and lungs or the clotting condition of their blood may develop venous thromboembolic disease just from ordinary hospital procedures. According to the NIH, "The most severe form of the venous thromboembolic disease is pulmonary embolism (PE), which remains the most preventable cause of death among hospitalized patients." IVC filters temporarily capture blood clots that develop after surgery during blood anticoagulant treatment. Prolonged hospitalization and the resultant immobility is also a leading cause of pulmonary embolism. IVC filters should be removed within a month or two which will minimalize the complications that may occur. Hundreds of patients with pulmonary emboli that have been unable to have their IVC filters removed due to the device migrating and damaging other organs and tissues have filed Bard IVC filter lawsuits seeking reimbursement for medical expenses, lost wages, and to compensate for pain and suffering.

Researchers writing for the NIH believe that the damages that the IVC filter causes to patients are beyond the control of doctors and are due to the device's inherently unreliable design. The complications of an implantable medical device are more serious than are admitted as the body naturally rejects any foreign material put into it. The IVC filter is a sharp spider-like metal object that causes irritation and scar tissue to develop to hold it in place. Reports indicate the device may tilt sideways and penetrate the inferior vena cava and could migrate and become embedded in the lungs. Doctors that implanted the device have little experience in locating and retrieving it. The IVC filter is effective in trapping blood clots but not perfect in keeping them trapped and as such, the device itself becomes the source of clots if it is not removed promptly.

More Recent IVC Filter Lawsuit News:

No-Cost, No-Obligation Bard IVC Filter Lawsuit Case Review for Persons or Families of Persons Who Suffered from Organ Damage, Severe Bleeding, Stroke, or Death

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.